Stanford University
Showing 1,601-1,620 of 3,294 Results
-
Rizwan Hassan Shinwari
Visiting Instructor, Neurosurgery
BioRizwan Hassan Shinwari is a Visiting Instructor in the Department of Neurosurgery at Stanford University. His research focuses on the clinical outcomes and adverse effects associated with stereotactic radiosurgery, with the goal of optimizing patient care and advancing neurosurgical precision.
Dr. Shinwari earned his medical degree from Khyber Medical College and brings a strong background in clinical medicine and surgical sciences. His academic and professional interests lie at the intersection of neurosurgery, radiological innovation, and patient-centered outcomes research. He aspires to further his training and career as a neurosurgeon in the United States. -
Josh Shiode
Managing Director, KIPAC
BioJosh Shiode is Managing Director of the Kavli Institute for Particle Astrophysics and Cosmology (KIPAC), a joint institute of Stanford University and the SLAC National Laboratory. Prior to joining KIPAC, Josh served as Senior Advisor and Chief of Staff in the U.S. Department of Energy Office of Science, under the leadership of then Director Asmeret Asefaw Berhe. Josh received his PhD in astrophysics from UC Berkeley in 2013, and subsequently worked in a variety of science and technology policy roles in Washington, DC, including with the American Association for the Advancement of Science and the Pacific Northwest National Laboratory.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Siddu Shivanagoudra
Postdoctoral Scholar, Gastroenterology
BioSiddu Shivanagoudra is a postdoctoral scholar in the Spencer Lab investigating how gut microbiota-derived metabolites modulate intestinal immune signaling and barrier function. He holds an MS in Horticultural Sciences and a PhD in Biomedical Engineering from Texas A&M University. His work spans tryptophan metabolite biology, AHR/GPR35 signaling, and defined bacterial consortia, integrating cellular, transcriptomic, and metabolomic approaches. Siddu aims to translate these mechanistic insights into microbiome-targeted therapeutic strategies for inflammatory gut diseases.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology.
